In vitro adenovirus mediated gene transfer to the human cornea

British Journal of Ophthalmology

Volumn 89, Issue 6, 2005, Pages 658-661

  Jessup, C F ^a   Brereton, H M ^a   Coster, D J ^a   Williams, Keryn A ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DENSITY; CORNEA; CORNEA ENDOTHELIUM; CRYOPRESERVATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; MONITORING; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; REPORTER GENE; SUPERNATANT; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ADENOVIRIDAE; AGED; AGED, 80 AND OVER; COLD; ENDOTHELIUM, CORNEAL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 20344394186     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.061754     Document Type: Article

References (24)

1. Williams KA, Muehlberg SM, Lewis RF, et al. How successful is corneal transplantation? A report from the Australian Corneal Graft Register. Eye 1995;9:219-27.
2. Pleyer U, Bertelmann E, Rieck P, et al. Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4. Graefes Arch Clin Exp Ophthalmol 2000;238:531-6.
3. Klebe S, Sykes P, Coster D, et al. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 2001;71:1214-20.
4. Comer RM, King WJ, Ardjomand N, et al. Effect of administration of CTLA4-lg as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci 2002;43:1095-103.
5. Muller A, Zhang EP, Schroff M, et al. Influence of ballistic gene transfer on antigen-presenting cells in murine corneas. Graefes Arch Clin Exp Ophthalmol 2002;240:851-9.
6. George AJ, Arancibia-Carcamo CV, Awad HM, et al. Gene delivery to the corneal endothelium. Am J Respir Crit Care Med 2000;162:5194-200.
7. Williams KA, Jessup CF, Coster DJ. Gene therapy approaches to prolonging corneal allograft survival. Expert Opin Biol Ther 2004;4:1059-71.
8. Pleyer U, Ritter T. Gene therapy in immune-mediated diseases of the eye. Prog Retin Eye Res 2003;22:277-93.
9. Orol HB, Larkin DF, Fehervari Z, et al. Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther 1997;4:639-47.
10. Loewen N, Fautsch MP, Peretz M, et al. Genetic modification of human trabecular meshwork with lentiviral vectors. Hum Gene Ther 2001;12:2109-19.
11. Hudde T, Rayner SA, Comer RM, et al. Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium. Gene Ther 1999;6:939-43.
12. Shewring L, Collins L, Lightman SL, et al. A nonviral vector system for efficient gene transfer to corneal endothelial cells via membrane integrins. Transplantation 1997;64:763-9.
13. Thiel MA, Coster DJ, Standfield SD, et al. Penetration of engineered antibody fragments into the eye. Clin Exp Immunol 2002;128:67-74.
14. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509-14.
15. Bertelmann E, Ritter T, Vogt K, et al. Efficiency of cytokine gene transfer in corneal endothelial cells and organ-cultured corneas mediated by liposomal vehicles and recombinant adenovirus. Ophthalmic Res 2003;35:117-24.
16. Larkin DF, Oral HB, Ring CJ, et al. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 1996;61:363-70.
17. Qian Y, Leong FL, Kazlauskas A, et al. Ex vivo adenovirus-mediated gene transfer to corned graft endothelial cells in mice. Invest Ophtholmol Vis Sci 2004;45:2187-93.
18. Crystal RG. The gene as the drug. Nat Med 1995;1:15-7.
19. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Ther 2003;10:977-82.
20. Somia N, Verma IM. Gene therapy: trials and tribulations. Not Rev Genet 2000;1:91-9.
21. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4:346-58.
22. O'Neal WK, Zhou H, Morral N, et al. Toxicily associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector. Mol Med 2000;6:179-95.
23. Borras T, Tamm ER, Zigler JS Jr. Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest Ophthalmol Vis Sci 1996;37:1282-93.
24. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-6.